242 related articles for article (PubMed ID: 1309596)
1. Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers.
Wang SW; Speck NA
Mol Cell Biol; 1992 Jan; 12(1):89-102. PubMed ID: 1309596
[TBL] [Abstract][Full Text] [Related]
2. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor.
Wang S; Wang Q; Crute BE; Melnikova IN; Keller SR; Speck NA
Mol Cell Biol; 1993 Jun; 13(6):3324-39. PubMed ID: 8497254
[TBL] [Abstract][Full Text] [Related]
3. Two factors that bind to highly conserved sequences in mammalian type C retroviral enhancers.
Manley NR; O'Connell M; Sun W; Speck NA; Hopkins N
J Virol; 1993 Apr; 67(4):1967-75. PubMed ID: 8445718
[TBL] [Abstract][Full Text] [Related]
4. Indistinguishable nuclear factor binding to functional core sites of the T-cell receptor delta and murine leukemia virus enhancers.
Redondo JM; Pfohl JL; Hernandez-Munain C; Wang S; Speck NA; Krangel MS
Mol Cell Biol; 1992 Nov; 12(11):4817-23. PubMed ID: 1328863
[TBL] [Abstract][Full Text] [Related]
5. The role of viral enhancer "core" motif-related sequences in regulating T cell receptor-gamma and -delta gene expression.
Hsiang YH; Spencer D; Wang S; Speck NA; Raulet DH
J Immunol; 1993 May; 150(9):3905-16. PubMed ID: 8473739
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a protein that binds multiple sequences in mammalian type C retrovirus enhancers.
Sun W; O'Connell M; Speck NA
J Virol; 1993 Apr; 67(4):1976-86. PubMed ID: 8445719
[TBL] [Abstract][Full Text] [Related]
7. Core-binding factor influences the disease specificity of Moloney murine leukemia virus.
Lewis AF; Stacy T; Green WR; Taddesse-Heath L; Hartley JW; Speck NA
J Virol; 1999 Jul; 73(7):5535-47. PubMed ID: 10364302
[TBL] [Abstract][Full Text] [Related]
8. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity.
Speck NA; Renjifo B; Golemis E; Fredrickson TN; Hartley JW; Hopkins N
Genes Dev; 1990 Feb; 4(2):233-42. PubMed ID: 2338244
[TBL] [Abstract][Full Text] [Related]
9. In vivo footprinting of the enhancer sequences in the upstream long terminal repeat of Moloney murine leukemia virus: differential binding of nuclear factors in different cell types.
Granger SW; Fan H
J Virol; 1998 Nov; 72(11):8961-70. PubMed ID: 9765441
[TBL] [Abstract][Full Text] [Related]
10. Point mutations in the Moloney murine leukemia virus enhancer identify a lymphoid-specific viral core motif and 1,3-phorbol myristate acetate-inducible element.
Speck NA; Renjifo B; Hopkins N
J Virol; 1990 Feb; 64(2):543-50. PubMed ID: 2104942
[TBL] [Abstract][Full Text] [Related]
11. Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins.
Sun W; Graves BJ; Speck NA
J Virol; 1995 Aug; 69(8):4941-9. PubMed ID: 7609063
[TBL] [Abstract][Full Text] [Related]
12. Second-site proviral enhancer alterations in lymphomas induced by enhancer mutants of SL3-3 murine leukemia virus: negative effect of nuclear factor 1 binding site.
Ethelberg S; Hallberg B; Lovmand J; Schmidt J; Luz A; Grundström T; Pedersen FS
J Virol; 1997 Feb; 71(2):1196-206. PubMed ID: 8995642
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factors that bind to the enhancer region of nondefective Friend murine leukemia virus.
Manley NR; O'Connell MA; Sharp PA; Hopkins N
J Virol; 1989 Oct; 63(10):4210-23. PubMed ID: 2778872
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of a protein fraction that binds to enhancer core sequences in intracisternal A-particle long terminal repeats.
Falzon M; Kuff EL
J Biol Chem; 1989 Dec; 264(36):21915-22. PubMed ID: 2513327
[TBL] [Abstract][Full Text] [Related]
15. Mutation of all Runx (AML1/core) sites in the enhancer of T-lymphomagenic SL3-3 murine leukemia virus unmasks a significant potential for myeloid leukemia induction and favors enhancer evolution toward induction of other disease patterns.
Sørensen KD; Quintanilla-Martinez L; Kunder S; Schmidt J; Pedersen FS
J Virol; 2004 Dec; 78(23):13216-31. PubMed ID: 15542674
[TBL] [Abstract][Full Text] [Related]
16. Purification of the pets factor. A nuclear protein that binds to the inducible TG-rich element of the human immunodeficiency virus type 2 enhancer.
Fu GK; Markovitz DM
J Biol Chem; 1996 Aug; 271(32):19599-605. PubMed ID: 8702655
[TBL] [Abstract][Full Text] [Related]
17. Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants.
Amtoft HW; Sørensen AB; Bareil C; Schmidt J; Luz A; Pedersen FS
J Virol; 1997 Jul; 71(7):5080-7. PubMed ID: 9188573
[TBL] [Abstract][Full Text] [Related]
18. Murine helix-loop-helix transcriptional activator proteins binding to the E-box motif of the Akv murine leukemia virus enhancer identified by cDNA cloning.
Nielsen AL; Pallisgaard N; Pedersen FS; Jørgensen P
Mol Cell Biol; 1992 Aug; 12(8):3449-59. PubMed ID: 1321336
[TBL] [Abstract][Full Text] [Related]
19. Distinct segments within the enhancer region collaborate to specify the type of leukemia induced by nondefective Friend and Moloney viruses.
Golemis E; Li Y; Fredrickson TN; Hartley JW; Hopkins N
J Virol; 1989 Jan; 63(1):328-37. PubMed ID: 2783259
[TBL] [Abstract][Full Text] [Related]
20. Identification of ETS domain proteins in murine T lymphocytes that interact with the Moloney murine leukemia virus enhancer.
Gunther CV; Graves BJ
Mol Cell Biol; 1994 Nov; 14(11):7569-80. PubMed ID: 7935472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
